Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
- PMID: 33162877
- PMCID: PMC7584050
- DOI: 10.3389/fnins.2020.531763
Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
Abstract
Objective: Antipsychotic medication non-adherence has detrimental effects on patients' clinical outcome. It is unclear which risk factors affect adherence most and which interventions are effective at improving adherence to antipsychotic medication. The aim of this systematic review is to summarize evidence exploring risk factors of non-adherence to antipsychotic treatment and effectiveness of intervention to improve adherence in patients with psychotic spectrum disorders. Methods: We conducted a systematic search in PubMed from 1994 to 2019 using a structured search strategy. Studies were quality assessed, and studies reporting on possible risk factors and intervention strategies were synthesized. Results: We reviewed 26 studies on factors related to antipsychotic medication adherence and 17 studies on interventions to improve adherence in patients with psychosis spectrum disorders. Risk factors of non-adherence included younger age, poor illness insight, cannabis abuse, and the presence of severe positive symptoms. Antipsychotic medication adherence was associated with positive attitude toward medication of both patients and their family, family involvement, and illness insight. Somewhat consistent evidence was found for interventions involving family and technology-based interventions and strategies combining depot medication with psychoeducation. However, given the wide range of heterogeneous interventions and methodological limitations, findings must be interpreted with caution. Conclusion: Despite much effort invested in the research area of antipsychotic medication adherence, the heterogeneity in study design and outcome, adding to confounding effects and possible biases, and methodological restraints complicate comparability of the results. Future research in this field should therefore be conducted on patient-tailored interventions, considering risk factors affecting the patient and implementing well-validated, standardized assessment methods. Accordingly, this systematic review seeks to facilitate endeavors improving adherence to antipsychotic treatment by identifying modifiable and non-modifiable risk factors, outlining effective intervention strategies, and proposing recommendations to enhance adherence strategies.
Keywords: adherence; antipsychotic; compliance; non-adherence; psychosis; schizophrenia; therapeutic drug monitoring.
Copyright © 2020 El Abdellati, De Picker and Morrens.
Figures
Similar articles
-
A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.J Psychiatr Ment Health Nurs. 2015 Sep;22(7):491-501. doi: 10.1111/jpm.12210. Epub 2015 May 20. J Psychiatr Ment Health Nurs. 2015. PMID: 25990303
-
[Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].Encephale. 2013 May;39 Suppl 1:S8-14. doi: 10.1016/j.encep.2012.03.005. Epub 2013 Mar 28. Encephale. 2013. PMID: 23541914 French.
-
[Relationships between insight and medication adherence in subjects with psychosis].Encephale. 2003 Sep-Oct;29(5):430-7. Encephale. 2003. PMID: 14615692 French.
-
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.Patient Prefer Adherence. 2017 Mar 3;11:449-468. doi: 10.2147/PPA.S124658. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28424542 Free PMC article. Review.
-
Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.J Clin Psychiatry. 2002 Oct;63(10):892-909. doi: 10.4088/jcp.v63n1007. J Clin Psychiatry. 2002. PMID: 12416599 Review.
Cited by
-
Epidemiology of infection, transmission and COVID-19 outcomes among mental health users and workers in a comprehensive network of long-term mental health facilities: Retrospective observational population-base study.Schizophr Res. 2023 Apr;254:1-7. doi: 10.1016/j.schres.2023.01.020. Epub 2023 Jan 20. Schizophr Res. 2023. PMID: 36736100 Free PMC article.
-
Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients.Ther Drug Monit. 2024 Dec 1;46(6):828-836. doi: 10.1097/FTD.0000000000001227. Epub 2024 Jun 3. Ther Drug Monit. 2024. PMID: 38833576 Free PMC article.
-
Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system.Schizophrenia (Heidelb). 2024 Feb 29;10(1):28. doi: 10.1038/s41537-024-00448-2. Schizophrenia (Heidelb). 2024. PMID: 38424086 Free PMC article. Review.
-
Revisiting Drug Compliance: The Need for a Holistic Approach in the Treatment of Severe Mental Disorders.Consort Psychiatr. 2021 Nov 5;2(3):17-25. doi: 10.17816/CP93. eCollection 2021. Consort Psychiatr. 2021. PMID: 39044752 Free PMC article.
-
Long-Acting Injectable Antipsychotic Use and Discontinuation Rates in Children and Adolescents With Schizophrenia Using Medicaid Claims Data.Early Interv Psychiatry. 2025 Jun;19(6):e70063. doi: 10.1111/eip.70063. Early Interv Psychiatry. 2025. PMID: 40525645 Free PMC article.
References
-
- Acosta F. J., Bosch E., Sarmiento G., Juanes N., Caballero-Hidalgo A., Mayans T. (2009). Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables. Schizophr. Res. 107, 213–217. 10.1016/j.schres.2008.09.007 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources